INNOVATIVE LAURIAD® MUCOADHESIVE DELIVERY SYSTEM

  OVERVIEW OF THE LAURIAD® TECHNOLOGY

• Innovative and patented drug delivery system based on a mucoadhesive tablet developed to ensure targeted diffusion and increase patient compliance.

 

• The tablet formulation is based on a novel natural biodegradable polymer derived from milk protein concentrate (MPC) in combination with hydrophilic matrix made of hypromellose, associated with active pharmaceutical ingredient (API).

 

• When applied under a patient’s upper lip, the tablet slowly swells, adheres and dissolves within 12‐16 hours, allowing the slow release of the API.

vectans_visuel_bouche2
BB-New-Etape-1D

• Buccal tablet applied to the canine fossa
• Penetration of water and hydration of hypromellos

Resulting an immediate mucoadhesion

BB-New-Etape-2

• Adhesion to the gum
• Hydration of milk proteins and protein interaction

Prolonged mucoadhesion

BB-New-Etape-3F

• Progressive release of active compound thanks to the hypromellose

Release of the API and then complete disintegration of the tablet